Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga August 26, 2014 at 08:11 AM EDT Kite Pharma (NASDAQ: KITE) jumped 19.06% to $26.55 in pre-market trading on positive non-Hodgkin's lymphoma trial results using KTE-C19. ... Read More >> Related Stocks: Achison Inc Elbit Imaging Ltd Kandi Techs Group